Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many pharmacies have bought coded stamped lateral flow tests for collection by immunocompromised patients from 17 November.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The NHS Lateral Flow Device (LFD) tests supply service for patients potentially eligible for COVID-19 treatments was launched on 6 November 2023. Information about how many pharmacies have supplied LFD tests will not be available until pharmacies have claimed for the delivery of the service.
Jun. 15 2023
Source Page: Q2 KPI Screening Data (1 July to 30 September)Found: Q2 KPI Screening Data (1 July to 30 September)
Written Evidence Jun. 27 2023
Inquiry: Coronavirus and Scotland follow-upFound: CSFU0013 - Coronavirus and Scotland follow-up Food and Drink Federation Scotland Written Evidence
May. 07 2024
Source Page: Communal accommodation settings: infectious disease transmissionFound: Screening on full text was undertaken by one reviewer and c hecked by a second.
Jun. 08 2023
Source Page: Q3 KPI Screening Data (1 October to 31 December)Found: Q3 KPI Screening Data (1 October to 31 December)
Asked by: Matt Vickers (Conservative - Stockton South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the Government's figures on covid-19 cases in the UK, whether that figure includes results from all types of covid-19 testing kits.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The ‘Coronavirus (COVID-19) in the UK’ dashboard provides a summary of key information about the pandemic. This includes levels of infections, the impact on health in the United Kingdom and on measures taken to respond. The UK Health Security Agency also publishes the National Influenza and COVID-19 Report which includes the number of episodes of infection and test positivity over time.
Case numbers include results from Pillar 1 (polymerase chain reaction) testing, which represents tests undertaken for healthcare purposes and in public health laboratories. They also include results from people who have reported a positive lateral flow test from the National Health Service on GOV.UK. Lateral flow tests that are privately purchased cannot currently be registered on GOV.UK
Changes to testing policies over time affect surveillance data. Fewer tests being performed, and tests limited to certain settings, would need to be considered when interpreting surveillance data. Nonetheless, surveillance metrics based on current testing continue to provide useful indicators of recent trends and disease acuity.
Asked by: Daisy Cooper (Liberal Democrat - St Albans)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make it his policy to ensure that results from privately purchased rapid lateral flow tests for Covid-19 can be reported on the Gov.uk website.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Lateral flow device (LFD) tests which are privately purchased cannot currently be registered on GOV.UK and there is no requirement to report these results to the provider. There are currently no plans to change the policy on reporting private COVID-19 test results.
For citizens that are eligible to order free LFD tests from the UK Health Security Agency, these tests can still be registered on GOV.UK.
Apr. 12 2023
Source Page: COVID-19: effectiveness of N95 masks in community settingsFound: Full text screening and screening of included studies from our previous review of the effectiveness
Jul. 17 2023
Source Page: Coronavirus Job Retention Scheme: quantitative research with employers (Wave 2)Found: Coronavirus Job Retention Scheme: quantitative research with employers (Wave 2)
Mar. 14 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023Found: severe acute respiratory syndrome coronavirus 2 (SARS -CoV-2) causes coronavirus disease 2019 (COVID